- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00710060
Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations
NIMH Collaborative HIV/STD Prevention Trial
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
The HIV/AIDS epidemic remains largely out of control in many areas of the world, with an estimated 2.5 million new HIV infections worldwide in 2007. Developing countries with few economic resources and world regions undergoing difficult social transitions have been particularly impacted by large increases in HIV and sexually transmitted disease (STD) infections. To date, effective individual prevention approaches have not been rapid enough to avert the epidemic in these areas and may be too resource intensive to maintain. Behavioral HIV prevention interventions on the community level seek to reduce the prevalence of high-risk sexual behaviors by reaching large numbers of vulnerable people in a cost-effective and feasible manner, even in areas with limited resources. The Community Popular Opinion Leader (C-POL) program is an HIV prevention intervention that recruits and trains trusted opinion leaders in the community to promote safe sex behaviors through risk-reduction conversations with peers. Implementing the C-POL program in world regions facing significant HIV/AIDS epidemics may be the most effective means of encouraging behavior change among members of at-risk populations and strengthening social norms to maintain these changes. This study will evaluate the effectiveness of the C-POL program in promoting safer sexual behaviors and reducing the transmission of HIV/STDs among at-risk populations in China, India, Peru, Russia, and Zimbabwe.
Participation in this study will last 2 years. Initially, an ethnographic study will be conducted to determine the HIV/STD knowledge, attitudes, and behaviors among the population living in the target communities. Information collected via observation, focus groups, and interviews will be used to determine the social risk groups operating within the community and to identify and recruit the opinion leaders who are influential in these groups. Also, an epidemiological study will be conducted to collect information on sexual behaviors and HIV/STD rates.
A cohort of members from participating communities will first undergo baseline assessments that will include a survey about general health and knowledge of HIV/STDs and a biological sampling for HIV/STD testing. Participating communities will then be assigned randomly to receive the C-POL intervention and HIV/STD educational materials or HIV/STD educational materials alone. In communities receiving the C-POL intervention, the previously recruited opinion leaders will be taught skills for sharing HIV risk-reduction messages in daily conversation with peers. This training will occur over four to five weekly sessions. At least 15% of the community population will be trained as opinion leaders. After the initial training, opinion leaders will attend six to nine booster sessions over the next 2 years to reinforce and support continued conversation efforts. Communities assigned to receive the HIV/STD educational materials will receive informational materials on HIV/STDs to provide to community members and will provide treatment or treatment referral for people with nonviral STDs.
All participants in the baseline cohort will be asked to repeat the baseline testing 1 and 2 years later. Participants who are not able to visit a clinic for testing will be contacted by phone to complete the baseline survey. After the 2-year assessments, the C-POL intervention will be conducted in the communities that received educational materials only.
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 3
Contactos e Locais
Locais de estudo
-
-
-
Fuzhou, China, 350003
- Fujian Institute of Health Education
-
-
-
-
-
St. Petersburg, Federação Russa, 197110
- Biomedical Center
-
-
-
-
-
Lima, Peru
- Universidad Peruana Cayetano Heredia
-
-
-
-
-
Harare, Zimbábue
- Zimbabwe Community Health Intervention Research (ZiCHIRe) - University of Zimbabwe
-
-
-
-
-
Chennai, Índia, 600 113
- YRG Centre for AIDS Research and Education (YRGCARE)
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Either lives, works, or socializes in the selected venues
- Plans to remain in the venue for at least 1 year after study entry
Exclusion Criteria:
- Permanent disability that hinders participation (e.g. deaf, mental retardation)
- Reports no sex in the 6 months before study entry (China, Peru)
- No STDs present at study entry (China)
- Enrolled in final year of school at time of recruitment (Russia)
- Has lived in venue for less than 2 years (Zimbabwe)
- Lives in venue for less than 9 months out of a year (Zimbabwe)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: 1
Participating communities will receive the Community Popular Opinion Leader intervention and HIV/STD educational materials.
|
The C-POL intervention will teach identified opinion leaders to share personalized HIV prevention messages in conversations with peers in an effort to change community norms.
Opinion leaders will be taught skills for sharing HIV risk-reduction messages during four to five weekly training sessions.
At least 15% of the community population will be trained as opinion leaders.
After the initial training, opinion leaders will attend six to nine booster sessions over the next 2 years to reinforce and support continued conversation efforts.
Outros nomes:
Communities will receive HIV/STD educational materials and treatment referral information to distribute to community members.
|
|
Comparador Ativo: 2
Participating communities will receive HIV/STD educational materials only.
|
Communities will receive HIV/STD educational materials and treatment referral information to distribute to community members.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Frequency of unprotected sexual acts with nonspousal partners
Prazo: Measured at baseline and Years 1 and 2
|
Measured at baseline and Years 1 and 2
|
|
Overall observed incidence of sexually transmitted diseases (STDs) (e.g., chlamydia, gonorrhea, syphilis, trichomonas, HIV, or herpes simplex virus-2), as detected by biological specimens
Prazo: Measured at baseline and Years 1 and 2
|
Measured at baseline and Years 1 and 2
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Increased exposure to HIV prevention messages, more STD treatment seeking, lower stigma regarding HIV and STDs, and lower substance abuse associated with sexual behavior in intervention group as compared to control group
Prazo: Measured at Year 2
|
Measured at Year 2
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Carlos F. Caceres, PhD, Cayetano Heredia University, Lima, Peru
- Investigador principal: David D. Celentano, ScD, The Johns Hopkins University, Baltimore, Maryland (India)
- Investigador principal: Thomas J. Coates, PhD, University of California at Los Angeles, Los Angeles, California (Peru)
- Investigador principal: Tyler D. Hartwell, PhD, RTI International, Research Triangle Park, North Carolina (DCC)
- Investigador principal: Danuta Kasprzyk, PhD, Battelle Center for Public Health Research and Evaluation, Seattle, Washington (Zimbabwe)
- Investigador principal: Jeffrey A. Kelly, PhD, Medical College of Wisconsin, Milwaukee, Wisconsin (Russia)
- Investigador principal: Andrei P. Kozlov, PhD, Biomedical Center, St. Petersburg State University, St. Petersburg, Russia
- Investigador principal: Willo Pequegnat, PhD, National Institute of Mental Health, Bethesda, Maryland
- Investigador principal: Mary Jane Rotheram-Borus, PhD, University of California at Los Angeles, Los Angeles, California (China)
- Investigador principal: Suniti Solomon, MD, YRG Centre for AIDS Research and Education, Chennai, India
- Investigador principal: Godfrey B. Woelk, PhD, University of Zimbabwe Medical School, Harare, Zimbabwe
- Investigador principal: Zunyou Wu, MD, PhD, Chinese Center for Disease Control and Prevention, Beijing, P.R. China
Publicações e links úteis
Publicações Gerais
- NIMH Collaborative HIV/STD Prevention Trial Group. The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures. AIDS. 2007 Apr;21 Suppl 2:S59-68. doi: 10.1097/01.aids.0000266458.49138.fa.
- NIMH Collaborative HIV/STD Prevention Trial Group. Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS. 2007 Apr;21 Suppl 2:S91-8. doi: 10.1097/01.aids.0000266461.33891.d0.
- NIMH Collaborative HIV/STD Prevention Trial Group. Methodological overview of a five-country community-level HIV/sexually transmitted disease prevention trial. AIDS. 2007 Apr;21 Suppl 2:S3-18. doi: 10.1097/01.aids.0000266453.18644.27.
- NIMH Collaborative HIV/STD Prevention Trial Group. Selection of populations represented in the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007 Apr;21 Suppl 2:S19-28. doi: 10.1097/01.aids.0000266454.26268.90.
- NIMH Collaborative HIV/STD Prevention Trial Group. Challenges and processes of selecting outcome measures for the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007 Apr;21 Suppl 2:S29-36. doi: 10.1097/01.aids.0000266455.03397.08.
- NIMH Collaborative HIV/STD Prevention Trial Group. Design and integration of ethnography within an international behavior change HIV/sexually transmitted disease prevention trial. AIDS. 2007 Apr;21 Suppl 2(Suppl 2):S37-48. doi: 10.1097/01.aids.0000266456.03397.d3.
- NIMH Collaborative HIV/STD Prevention Trial Group. The feasibility of audio computer-assisted self-interviewing in international settings. AIDS. 2007 Apr;21 Suppl 2:S49-58. doi: 10.1097/01.aids.0000266457.11020.f0.
- NIMH Collaborative HIV/STD Prevention Trial Group. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007 Apr;21 Suppl 2:S69-80. doi: 10.1097/01.aids.0000266459.49138.b3.
- NIMH Collaborative HIV/STD Prevention Trial Group. Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings. AIDS. 2007 Apr;21 Suppl 2:S81-90. doi: 10.1097/01.aids.0000266460.56762.84.
- NIMH Collaborative HIV/STD Prevention Trial. Role of the data safety and monitoring board in an international trial. AIDS. 2007 Apr;21 Suppl 2:S99-102. doi: 10.1097/01.aids.0000266462.33891.0b.
- Rotheram-Borus MJ, Wu Z, Liang LJ, Li L, Detels R, Guan J, Yin Y, Swendeman D; NIMH Collaborative HIV/STD Prevention Trial Group. Reductions in sexually transmitted infections associated with popular opinion leaders in China in a randomised controlled trial. Sex Transm Infect. 2011 Jun;87(4):337-43. doi: 10.1136/sti.2010.046243. Epub 2011 Jan 29.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- U10MH061537 (Concessão/Contrato do NIH dos EUA)
- DAHBR 9A-ASGT
- U10MH061499 (Concessão/Contrato do NIH dos EUA)
- U10MH061513 (Concessão/Contrato do NIH dos EUA)
- U10MH061536 (Concessão/Contrato do NIH dos EUA)
- U10MH061543 (Concessão/Contrato do NIH dos EUA)
- U10MH061544 (Concessão/Contrato do NIH dos EUA)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .